<p>Mind Medicine Inc. MNMD said Thursday a Phase 2 trial testing LSD as a treatment for generalized anxiety disorder met its main goal, showing a statistically significant improvement in scores
<h2><span>Daily Market Outlook, June 2, 2020 </span></h2> <p><span><strong>Asian equity market is largely up this morning following modest gains on Wall Stree
Leave a Comment